Earlier this month, we held our annual Ignite Golden Ticket Competition, where we had 11 companies pitch to win one of five Golden Tickets being awarded! Sponsored by Bayer, Eli Lilly and Company, Takeda, and Pfizer, a total of $250K was given away in one night! Congrats again to the winners: DoriNano, KiraGen Bio, Laurel Biotherapeutics, Microvitality, and SequestBio 🎉 Catch the full story here 👉 https://lnkd.in/e3SYJUpn
LabCentral
Biotechnology Research
Cambridge, Massachusetts 13,865 followers
LabCentral is the premier shared lab community for innovative biotech startups. Home to 100 teams and growing fast!
About us
LabCentral is Cambridge, MA's premier network of shared laboratory spaces and scientific communities, designed to jumpstart the launch of promising early-stage life-sciences companies. Home to 100+ great teams and growing fast! Providing first-class operational support, curated events and programming, and access to a diverse network of sponsors, LabCentral prepares entrepreneurs and scientists to accelerate scientific innovation in service of human health.
- Website
-
http://labcentral.org
External link for LabCentral
- Industry
- Biotechnology Research
- Company size
- 51-200 employees
- Headquarters
- Cambridge, Massachusetts
- Type
- Nonprofit
- Founded
- 2013
- Specialties
- Laboratory Services, RNAi, drug development, FDA, toxicology, probiotics, contract research laboratory, cell culture, nanotechnology, drug delivery, high throughput screening, IND, NDA, BSL-2, cancer biology
Locations
-
Primary
Get directions
700 Main Street North
Cambridge, Massachusetts 02139, US
-
Get directions
610 Main St
Cambridge, Massachusetts 02139, US
-
Get directions
238 Main St
Cambridge, Massachusetts 02142, US
Employees at LabCentral
-
Timothy Rowe
Founder and CEO of CIC
-
Michael LaRhette
Helping entrepreneurs win and the global platforms that support them succeed by focusing on collaborative innovation and design
-
Elliston Kieng
Director of Information Services@ LabCentral
-
Tera Kull
Head of People Strategy & Culture | Non-Profit Co-Founder
Updates
-
We're buzzing from another incredible evening of innovation! Last night, we joined our partners at Daiichi Sankyo US for an exclusive networking event where attendees got an inside look at the company’s R&D strategy and heard directly from leaders shaping the future of biotech innovation. But the real highlight of the night? The announcement of their 2025 Autumn Golden Ticket winners — Amaryllis Therapeutics and GT Biosciences! 🎉 Following an engaging pitch event featuring five impressive finalists, these two outstanding teams each earned the #GoldenTicket, which provides $50,000 in funding towards space at LabCentral. We’re deeply grateful to Daiichi Sankyo US for their partnership and continued commitment to supporting the next generation of biotech leaders. Congratulations again to all of the finalists, your science and passion continue to inspire us all!
-
-
-
-
-
+13
-
-
Every episode of The Dish, Johannes Fruehauf kicks off with a warm-up where guests bring an orange object of their choice. Because, who doesn't love orange? 🍊 In our latest episode, David L. Lucchino brought along a staple for every entrepreneur — an orange dry erase marker. Because true innovation requires iteration. Tune in to this episode for a rare glimpse into what it takes to navigate biotech’s highs and lows, and why staying open to change is the key to success. 🎥 Watch the full episode of The Dish now: https://lnkd.in/eE_HtpTQ
-
Today marked the 5th anniversary of a LabCentral fan favorite, our #CulturalCelebration! 🌏 🛫 Residents, sponsors, and partners gathered for a food tour of the world with over 20 countries represented through food, drink and dress. We're always so inspired at the energy this event brings, and feel deeply honored to cultivate a community brimming with #culture and curiosity. Thank you to everyone who helped make this day so special! We can't possibly tag everyone who participated but please know we are so thankful for each of you! Now... time to nurse our #foodcoma
-
-
-
-
-
+5
-
-
Our friends at Sanofi have launched a very exciting opportunity for early startups who are advancing cutting-edge science & technologies! 🔬💡 Learn more below or by visiting their link. The deadline to apply is December 12 ⏰
🚀 Exciting News: Sanofi iDEA-TECH Awards 2025-2026 Applications Are Now Open! We're thrilled to announce that the Sanofi iDEA-TECH Awards North America is accepting applications for exciting research projects. 💡 What We're Offering: The iDEA-TECH Award provides $150,000 in funding to support 1-year projects led by academic researchers and early-stage startups who are pushing the boundaries of science and technology. 🔬 Focus Areas: We're seeking innovative proposals in: • Real-world evidence • Novel modalities • Advanced imaging • Multi-omics • Disease modeling • Process innovation • Safety assessment 📋 How to Apply: Visit our Application Page to access: ✓ Program Guidelines ✓ Pre-proposal Template ✓ Submission Portal: ⏰ Key Date: Pre-proposal submission deadline is December 12th, 2025 🔗 Learn More: Visit the Sanofi iDEA-TECH Awards North America for complete program details: https://lnkd.in/gaxMjB2f We're excited to discover the next wave of scientific innovations that will transform patient care. If you're working on emerging technologies that can impact the therapeutic pipeline, we want to hear from you! #SanofiIDEATECH #Innovation #Research #LifeSciences #Biotech #AcademicResearch #Startups #ScientificInnovation #ChaseTheMiraclesOfScience Karen Chandross, PhDMarie-Pierre Harnist, Annemarie Van Nieuwenhuijze, Yao X., Luke Hanlin, Wayne Rowe, Laura Chambre, PhD
-
THIS WEDNESDAY! Don't miss out on an evening of innovation and insights. Details & RSVP below 👇
Join us next week for Daiichi Sankyo US's Golden Ticket Pitch event, which will award two tickets totaling $100,000 in value! Winners of the Daiichi Sankyo US Golden Tickets receive a $50,000 credit towards space available at our flagship site in Kendall Square, along with access to Daiichi Sankyo US's team of skilled experts for guidance and feedback to early-stage companies. You won’t want to miss this special event! In addition to the pitches, attendees with also have the opportunity to interact directly with Global Head of Research Platform in R&D Division, one of the ADC pioneers who is now leading overall modality strategy and with Head of Research Institute in Boston. 🗓️ Wednesday, November 19th ⏰ 3:00PM – 6:30PM 📍 700 Main St. ✉️ https://lnkd.in/e_hE8Bss
-
-
Always thrilled to be represented by our Social Impact strategist, Shazia Mir! Her voice, perspective, and leadership continue to shape LabCentral’s mission to build a more inclusive, equitable, and community-driven biotech ecosystem. Shazia’s work reminds us that expanding access starts with asking the right questions: Whose story is missing? Who hasn’t been seen in this space before? Her commitment to bridging art, science, and community through Gallery 1832 reflects the heart of our social impact mission. Congratulations again, Shazia! We’re grateful for your vision and all the ways you help push us forward. 👏
Social Impact Programming and Mission-Driven Culture | Gallery Curator and Creative Strategist | Driving Brand Strength & Community Engagement
On equity: “Whose story is missing? Who hasn’t been seen in this space before?” These questions guide my work and ensure that curation becomes an act of expanding visibility, not reinforcing the familiar. On art and innovation: “Art inspires science, and science inspires art each pushing the other toward deeper curiosity and more inclusive impact.” Last night, I had the pleasure of joining an incredible panel at CIC (Cambridge Innovation Center) as part of the Visionary Crossings exhibition by Mao Miyamoto an evening that reaffirmed the power of bringing #art, #science, and #community into conversation with one another. Sitting alongside thoughtful voices like Tricia Bitetto, Stacey Messier, and Anupallavi Sinha, MPH was energizing. Together, we explored how creativity fuels innovation, how lived experience shapes discovery, and how art offers a lens of empathy and humanity that science urgently needs. It was especially meaningful to witness how Visionary Crossings has grown since its inception at Gallery 1832, and to see Mao continue cultivating spaces where these dialogues can thrive. If you’re in Kendall Square, I encourage you to visit CIC, One Broadway to experience the exhibition and please take a look at what’s ahead for Gallery 1832 at LabCentral in 2026 - our social impact events are open to the public, perfect for art and science enthusiasts, for networking, expanding community, and engaging in enriching dialogue - https://lnkd.in/eUqB9Kf6 I’m grateful for the invitation, the shared reflections, and the collective commitment to using creativity as a catalyst for change. When we center purpose and perspective in this way, the art becomes more than a visual experience it becomes a platform for belonging, imagination, and community impact.
-
-
Earlier this week, we announced LabCentral First, our new program giving first-time biotech founders six months of free lab space. In our latest blog, Abby Johnson goes behind the scenes to share how this program aligns with our mission to support the next generation of life sciences innovators, and why investing in early-stage founders is more important than ever in today’s funding environment. Catch the full story here 👉 https://lnkd.in/eM9AtZ-s
-
-
It's time to Dish!! 🧫🔬 The latest full episode of our video series, 'The Dish' just dropped on our YouTube channel! Full episode here 👉 https://lnkd.in/eRsUWJ5Q This time, Johannes Fruehauf sits down with David L. Lucchino to discuss lessons learned, the importance of adaptability in science and business, and how initiatives like Project Onramp Onramp are shaping the next generation of biotech leaders. Catch the full story on YouTube!
-
Join us next week for Daiichi Sankyo US's Golden Ticket Pitch event, which will award two tickets totaling $100,000 in value! Winners of the Daiichi Sankyo US Golden Tickets receive a $50,000 credit towards space available at our flagship site in Kendall Square, along with access to Daiichi Sankyo US's team of skilled experts for guidance and feedback to early-stage companies. You won’t want to miss this special event! In addition to the pitches, attendees with also have the opportunity to interact directly with Global Head of Research Platform in R&D Division, one of the ADC pioneers who is now leading overall modality strategy and with Head of Research Institute in Boston. 🗓️ Wednesday, November 19th ⏰ 3:00PM – 6:30PM 📍 700 Main St. ✉️ https://lnkd.in/e_hE8Bss
-